brequinar has been researched along with molnupiravir in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aittokallio, T; Biering, SB; Gale, M; Herring, S; Hoffmann, M; Hsiang, TY; Ianevski, A; Pöhlmann, S; Polyak, SJ; Schiffer, JT; Wagoner, J; White, JM; Xu, S | 1 |
1 other study(ies) available for brequinar and molnupiravir
| Article | Year |
|---|---|
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2.
Topics: Antiviral Agents; COVID-19 Drug Treatment; Drug Combinations; Humans; Protease Inhibitors; Pyrimidines; SARS-CoV-2 | 2022 |